About Indivumed
Indivumed is a company based in Hamburg (Germany) founded in 2002. The company has 178 employees as of December 31, 2021. Indivumed offers products and services including Unique Database, AI Tools, and Cellular Models. Indivumed operates in a competitive market with competitors including GenVault Corporation, iSpecimen, PrecisionMed, Cryoniss and AminoChain, among others.
- Headquarter Hamburg, Germany
- Employees 178 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Indivumed Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$47.97 M (USD), Debt – Conventional
Jan 09, 2018
-
Investors
European Investment Bank
& 1 more
-
Employee Count
178
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Indivumed
Indivumed offers a comprehensive portfolio of products and services, including Unique Database, AI Tools, and Cellular Models.
Comprehensive database of tumor samples for cancer research and discovery.
Biomathematical tools for target validation in oncology development.
Patient-derived models for validating cancer therapy targets.
People of Indivumed
Unlock access to complete
Software Development Team
5 people
Leadership Team
4 people
Data Analysis and Operations Team
3 people
Finance and Accounting
2 people
Scientist Team
2 people
Operations Team
2 people
Sales and Marketing
2 people
Legal and Compliance
1 people
Unlock access to complete
Funding Insights of Indivumed
Investors in Indivumed
Indivumed has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Investment Bank and National Cancer Institute.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Finance and advisory services for infrastructure projects are provided.
|
Locked | Locked | Locked | |
|
Cancer research is conducted and supported by the institute.
|
Locked | Locked | Locked |
Investor details for Indivumed
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Indivumed
Investment portfolio details for Indivumed
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Indivumed
Detailed financials for Indivumed
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Indivumed Comparisons
Peer comparison for Indivumed
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Indivumed
Indivumed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenVault Corporation, iSpecimen, PrecisionMed, Cryoniss and AminoChain, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biosamples are stabilized, transported, stored, and retrieved by GenVault.
|
|
| Locked | Locked | Locked |
Provider of a biorepository of human clinical specimens
|
|
| Locked | Locked | Locked |
Human biological materials for research are supplied via a biorepository.
|
|
| Locked | Locked | Locked |
Provider of biobanking services for life sciences industries
|
|
| Locked | Locked | Locked |
A blockchain-based platform for tokenizing and incentivizing stem cell donations
|
|
| Locked | Locked | Locked |
Provider of services for collecting and preserving umbilical cord blood stem cells
|
Detailed competitors of Indivumed
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Indivumed
Complete news archive for Indivumed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Indivumed
Indivumed was founded in 2002 and raised its 1st funding round 7 years after it was founded.
Indivumed is headquartered in Hamburg, Germany. It is registered at Hamburg, Hamburg, Germany.
As of Dec 31, 2021, the latest employee count at Indivumed is 178.
Indivumed was founded in 2002 in Hamburg, Germany, as an integrated oncology company. Biospecimens are collected and preserved rapidly for clinical trials, maintaining molecular patterns akin to those in the human body. Tumor tissue specimens and related molecular analytical services are provided, alongside drug and biomarker development including immunohistochemistry, phosphoprotein profiling, drug profiling, capture microdissection, and genomics services.
Indivumed's top competitors include iSpecimen, AminoChain and GenVault Corporation.
Indivumed offers Unique Database, AI Tools, and Cellular Models.
Indivumed has 2 investors. Key investors include European Investment Bank, and National Cancer Institute.